Live TVLatestMarketsBusinessEconomyResearch ReportsBeepsPersonal FinanceIndiaWorld
LIVE TV
App
Social
Hello Reader
Newsletters
Watchlist
Misc
About
Support
Terms of Use
Privacy Policy
Set as Trusted Source
on Google Search
Google Badge
  • Home
  • Science
  • Health

Health

  • Weekly HIV Treatment Nears Reality? Gilead, Merck Combo Shows Positive Phase 3 Results
    Weekly HIV Treatment Nears Reality? Gilead, Merck Combo Shows Positive Phase 3 Results

    The findings are due to be presented at the 26th International AIDS Conference in Rio de Janeiro.

    • Jul 22, 2026 18:14 pm IST
    • Author:  Vaishnavi Mishra
    • Edited by:  Hemarghya Bal
  • What Is The Bundibugyo Ebola Strain? DR Congo Outbreak Explained
    What Is The Bundibugyo Ebola Strain? DR Congo Outbreak Explained

    Health officials have warned that the outbreak, which is being driven by the uncommon Bundibugyo strain, is expanding at the quickest rate ever.

    • Jul 15, 2026 22:43 pm IST
    • Author:  Shafat Mir
    • Edited by:  Shrikant Shankar
  • First-At-Home Alzheimer's Treatment: US FDA Approves Eisai-Biogen's Weekly Self-Injection
    First-At-Home Alzheimer's Treatment: US FDA Approves Eisai-Biogen's Weekly Self-Injection

    The injection is expected to be available by late August 2026 in the US.

    • Jul 14, 2026 16:45 pm IST
    • Author:  Riya Alex
  • Prices Of Diabetes, Heart Disease, Hypertention And 36 Other Medicines Capped - Check Full List
    Prices Of Diabetes, Heart Disease, Hypertention And 36 Other Medicines Capped - Check Full List

    This move is expected to reduce out-of-pocket healthcare expenses, particularly for people requiring long-term treatment for chronic illnesses such as diabetes, hypertension and cardiovascular diseases.

    • Jul 12, 2026 00:27 am IST
    • Author:  NDTV Profit News
  • Cancer Crisis: India Among 6 Hardest-Hit Nations Leaving Children Without Mothers, Says WHO
    Cancer Crisis: India Among 6 Hardest-Hit Nations Leaving Children Without Mothers, Says WHO

    WHO estimates millions of children have lost their mothers to cancer, with India among the six countries contributing the largest share of the global burden.

    • Jul 10, 2026 05:10 am IST
    • Author:  NDTV Profit News
  • What Is Heart CT Scan And Why Is Dr Devi Shetty Recommending It To Everyone Over 35?
    What Is Heart CT Scan And Why Is Dr Devi Shetty Recommending It To Everyone Over 35?

    Dr Devi Shetty urges Indians to prioritise preventive heart screening, recommending routine checks from age 35 and earlier for diabetics or those with family heart disease history.

    • Jul 09, 2026 21:58 pm IST
    • Author:  Soumil Kamat
    • Edited by:  Shrikant Shankar
  • Ozone Pollution Spreading Across Indian Cities, Mumbai At High-Risk, CSE Warns
    Ozone Pollution Spreading Across Indian Cities, Mumbai At High-Risk, CSE Warns

    Mumbai recorded some of the highest ozone peaks, while Bengaluru and Chennai also showed worrying trends, according to the CSE analysis.

    • Jun 30, 2026 23:51 pm IST
    • Author:  Shafat Mir
    • Edited by:  Shrikant Shankar
  • Pfizer's Lung Cancer Drug Trial Fails To Boost Survival
    Pfizer's Lung Cancer Drug Trial Fails To Boost Survival

    Pfizer's experimental drug sigvotatug vedotin failed to improve survival in advanced non-small cell lung cancer patients compared to standard therapy, Pfizer announced.

    • Jun 23, 2026 12:38 pm IST
    • Author:  Bloomberg News
  • IIT Bombay-Led Team Develops Peptide That Cuts Cholesterol, Triglyceride Release By Nearly 50%
    IIT Bombay-Led Team Develops Peptide That Cuts Cholesterol, Triglyceride Release By Nearly 50%

    Researchers at IIT-B reported no harmful fat buildup in the liver, with excess fatty acids instead being broken down to produce energy.

    • Jun 23, 2026 05:01 am IST
    • Author:  Noor Ul Haq
    • Edited by:  Shrikant Shankar
  • Eli Lilly's Foundayo Tops Oral Semaglutide On Key Measures In Type 2 Diabetes Trial
    Eli Lilly's Foundayo Tops Oral Semaglutide On Key Measures In Type 2 Diabetes Trial

    Over 52 weeks, the Achieve-3 study compared two doses of Foundayo with approved oral semaglutide doses in 1,698 people with type 2 diabetes who were not adequately controlled on metformin.

    • Jun 10, 2026 21:44 pm IST
    • Author:  NDTV Profit News
    • Edited by:  Hemarghya Bal
VideosWatch  LIVE
QUICK LINKS
LatestWatchlistBreakout AlertsLive TVFuturesOptionsIPOs Tracker
QUICK LINKS
LatestWatchlistBreakout AlertsLive TVFuturesOptionsIPOs Tracker
ALL SECTIONS
MarketsBusinessEconomyResearch ReportsPersonal FinanceIndiaWorldTechnologySportsLifestyleScienceVideosGold PriceSilver PriceFuel PricesCalculators
ALL SECTIONS
MarketsBusinessEconomyResearch ReportsPersonal FinanceIndiaWorldTechnologySportsLifestyleScienceVideosGold PriceSilver PriceFuel PricesCalculators
STAY UPDATED
NewslettersTelegramPodcastsWhatsapp
STAY UPDATED
NewslettersTelegramPodcastsWhatsapp
OUR NEWSLETTERS
Sign Up

By signing up you agree to the Terms & Conditions of NDTV Profit

television
Get Support
Feel free to reach out to us
Follow Us
Note : All Stock Exchange data is delayed upto 3 mins
DISCOVER US FASTER
NewGoogle Badge
App  Scanner
DOWNLOAD THE APP
Play StoreApp Store
About us
Terms of Use
Privacy Policy
Sitemap
RSS
About us
Terms of Use
Privacy Policy
Sitemap
RSS
2026 © NDTV Profit. All Rights Reserved